Chabiotech Co.,Ltd. (085660.KQ)

KRW 15280.0

(-2.98%)

Revenue Summary of Chabiotech Co.,Ltd.

Chabiotech Co.,Ltd.'s latest annual revenue in 2023 was 953.95 Billion KRW , up 12.95% from previous year.
Chabiotech Co.,Ltd.'s latest quarterly revenue in 2024 Q2 was 264.64 Billion KRW , up 13.87% from previous quarter.
Chabiotech Co.,Ltd. reported a annual revenue of 844.58 Billion KRW in annual revenue 2022, up 16.1% from previous year.
Chabiotech Co.,Ltd. reported a annual revenue of 727.47 Billion KRW in annual revenue 2021, up 9.44% from previous year.
Chabiotech Co.,Ltd. reported a quarterly revenue of 232.4 Billion KRW for 2024 Q1, down -3.46% from previous quarter.
Chabiotech Co.,Ltd. reported a quarterly revenue of 953.95 Billion KRW for 2023 FY, up 12.95% from previous quarter.

Annual Revenue Chart of Chabiotech Co.,Ltd. (2023 - 2016)

Historical Annual Revenue of Chabiotech Co.,Ltd. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	953.95 Billion KRW	12.95%
2022	844.58 Billion KRW	16.1%
2021	727.47 Billion KRW	9.44%
2020	664.71 Billion KRW	24.34%
2019	534.61 Billion KRW	9.42%
2018	488.59 Billion KRW	17.04%
2017	417.45 Billion KRW	-7.08%
2016	449.26 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q2	264.64 Billion KRW	13.87%
2024 Q1	232.4 Billion KRW	-3.46%
2023 FY	953.95 Billion KRW	12.95%
2023 Q2	239.76 Billion KRW	1.41%
2023 Q3	237.01 Billion KRW	-1.14%
2023 Q4	240.73 Billion KRW	1.57%
2023 Q1	236.43 Billion KRW	3.15%
2022 Q2	211.67 Billion KRW	12.57%
2022 FY	844.58 Billion KRW	16.1%
2022 Q4	229.21 Billion KRW	6.28%
2022 Q3	215.66 Billion KRW	1.88%
2022 Q1	188.03 Billion KRW	-2.78%
2021 Q4	193.4 Billion KRW	3.84%
2021 FY	727.47 Billion KRW	9.44%
2021 Q3	186.25 Billion KRW	0.0%
2020 FY	664.71 Billion KRW	24.34%
2019 FY	534.61 Billion KRW	9.42%
2018 FY	488.59 Billion KRW	17.04%
2017 FY	417.45 Billion KRW	-7.08%
2016 FY	449.26 Billion KRW	0.0%

Peer Revenue Comparison of Chabiotech Co.,Ltd.

Name	Revenue	Revenue Difference
HLB Co., Ltd.	42.9 Billion KRW	-2123.634%
iNtRON Biotechnology, Inc.	9.58 Billion KRW	-9852.084%
BINEX Co., Ltd.	154.82 Billion KRW	-516.149%
Bioneer Corporation	263.23 Billion KRW	-262.393%
Anterogen.Co.,Ltd.	6.5 Billion KRW	-14575.612%
MEDIPOST Co., Ltd.	68.64 Billion KRW	-1289.729%
CrystalGenomics, Inc.	4.87 Billion KRW	-19453.54%
Helixmith Co., Ltd	4.2 Billion KRW	-22604.357%
Medy-Tox Inc.	221.12 Billion KRW	-331.417%
Peptron, Inc.	3.34 Billion KRW	-28445.236%
Amicogen, Inc.	159.9 Billion KRW	-496.577%
Genexine, Inc.	4.42 Billion KRW	-21450.301%
HLB Therapeutics Co.,Ltd.	53.74 Billion KRW	-1674.824%
LegoChem Biosciences, Inc.	34.14 Billion KRW	-2693.772%
ALTEOGEN Inc.	96.52 Billion KRW	-888.316%
PharmaResearch Co., Ltd.	261.01 Billion KRW	-265.483%
SillaJen, Inc.	3.93 Billion KRW	-24114.677%
JETEMA, Co., Ltd.	58.71 Billion KRW	-1524.685%
OliX Pharmaceuticals,Inc	17.06 Billion KRW	-5490.342%
Genomictree Inc.	3.41 Billion KRW	-27809.561%
MedPacto, Inc.	- KRW	-Infinity%
D&D Pharmatech	18.67 Billion KRW	-5007.614%
EASY BIO,Inc.	165.38 Billion KRW	-476.806%
GI Innovation, Inc.	5.31 Billion KRW	-17835.297%